A new self-amplifying mRNA vaccine for COVID-19 has been approved in Japan, marking a historic milestone. This vaccine instructs the body on how to make more mRNA, which has the potential to offer lower doses and induce a more durable immune response. The vaccine's approval reflects CSL's commitment to developing and delivering public health innovations. Researchers at New York University have conducted a study to understand how AI could learn like a baby, concluding that the insights could lead to better AI models.